Results 261 to 270 of about 1,877,507 (306)
Some of the next articles are maybe not open access.

Overall survival in patients with metastatic melanoma

Current Medical Research and Opinion, 2015
Patients with regionally or distantly metastatic melanoma have poor long-term prognosis. The objective of this analysis was to describe survival rates among patients diagnosed with unresectable stage IIIB/C or stage IV melanoma.Using data from the Surveillance, Epidemiology, and End Results (SEER) database, patients diagnosed with unresectable stage ...
Xue, Song   +5 more
openaire   +2 more sources

2015 And Human Cancer: Back to Overall Survival

Future Oncology, 2016
10.2217/fon-2015-0085 © 2016 Future Medicine Ltd At the end of the year, it is time to take stock. What has been the revolutionary innovation in oncology in 2015? Key steps in translational research are certainly strengthening the foundations of cancer knowledge. As genome sequencing has allowed outlining the mutational landscape of several tumor types
Ciccarese C., Massari F., Tortora G.
openaire   +3 more sources

Overall Treatment and Survival

1989
The overall pattern of gastric cancer presentation, treatment and outcome is described in this chapter. The results are described for all patients for the whole period and also by quinquennia or decades in order to evaluate changes occurring during the study period. Presentation is assessed by site and stage. The type of treatment is evaluated overall,
John W. L. Fielding   +4 more
openaire   +1 more source

FOXP3 Expression and Overall Survival in Breast Cancer

Journal of Clinical Oncology, 2009
PurposeThe transcription factor forkhead box P3 (FOXP3) up- or downregulates a large number of genes and has been recently reported to be expressed in tumor cells. We investigated the prognostic importance of FOXP3 expression in patients with breast cancer.Patients and MethodsThe expression patterns of FOXP3 were characterized by immunohistochemistry ...
A. Merlo   +7 more
openaire   +2 more sources

Recombinant human erythropoietin and overall survival

Current Oncology Reports, 2005
Although a trend was seen for increased thromboembolic events in patients treated with erythropoietin, there was also a trend for improved survival times in such patients.
openaire   +2 more sources

Radiogenomics model for overall survival prediction of glioblastoma

Medical & Biological Engineering & Computing, 2020
Glioblastoma multiforme (GBM) is a very aggressive and infiltrative brain tumor with a high mortality rate. There are radiomic models with handcrafted features to estimate glioblastoma prognosis. In this work, we evaluate to what extent of combining genomic with radiomic features makes an impact on the prognosis of overall survival (OS) in patients ...
Navodini Wijethilake   +2 more
openaire   +2 more sources

Brain Metastases: Surgical Treatment and Overall Survival

World Neurosurgery, 2017
Brain metastases occur in 10%-40% of patients with cancer and are more common than primary brain tumors (30%-40%); their incidence is growing because of improvements in control of systemic disease, better radiologic detection, and prolonged survival. Modern treatment of brain metastases has dramatically changed the expected prognosis.
D(')Andrea, G.   +4 more
openaire   +6 more sources

Overall survival in TP53-mutated AML and MDS

Annals of Hematology
TP53 mutations in patients with AML and MDS frequently portend a poor prognosis, related to both p53 allele status and blast count. In 2022, the ICC and WHO released updated guidelines for classifying p53-mutated AML/MDS. The characteristics of p53 mutations, their associated co-mutations, and their effects on overall survival (OS) are not known in the
Christian J. Puzo   +4 more
openaire   +2 more sources

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao   +2 more
exaly  

Home - About - Disclaimer - Privacy